NCT02579278View on ClinicalTrials.gov

Circulating Tumour DNA (ctDNA) in Patients With Colorectal Cancer and the Relationship to Imaging Features of Extramural Venous Invasion

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions

CancerRectal Cancer

Interventions

OTHER

Blood sample (mrEMVI positive patient)

Two blood samples are taken from each patient with mrEMVI positive tumours post chemoradiotherapy. One pre-surgery and one during surgery from a peripheral vein.

OTHER

Blood sample (mrEMVI negative patient)

Trial Locations (3)

CT9 4AN

RECRUITING

Queen Elizabeth the Queen Mother Hospital, Margate

W2 1NY

RECRUITING

St Mary's Hospital (Imperial), Hammersmith

SM2 5PT

RECRUITING

Royal Marsden Hospital NHS Foundation Trust, Sutton

All Listed Sponsors

lead

Imperial College London

OTHER

NCT02579278 - Circulating Tumour DNA (ctDNA) in Patients With Colorectal Cancer and the Relationship to Imaging Features of Extramural Venous Invasion | Biotech Hunter | Biotech Hunter